The Market for Restriction Enzymes: Cutting Out Your CompetitionBioInformatics, LLCFebruary 1, 2006 142 Pages - SKU: BIF1278364 |
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
Wound Care in Latvia
5/8/2012 | published by: Euromonitor International
Wound care increased its value share through non-health retailers in 2011. The share of more expensive brands increased in 2011 as consumers were willing to spend more on higher quality products. Producers postponed introduction of
|
more...
|
$900.00
|
|
Wound Care in Ukraine
5/10/2012 | published by: Euromonitor International
During the financial crisis wound care could not boast of new technological delivery formats or other progressive changes and remained one of the most mature categories in OTC consumer health in Ukraine. Consumer spending increased,
|
more...
|
$900.00
|
|
Freedonia Focus on Biotechnology -- Agriculture: United States
5/31/2012 | published by: Freedonia Focus
This report discusses US demand agricultural biotechnology for the years 2006 and 2011, with forecasts for 2016. Topics covered include market size; product segmentation; genetically modified crops; regulatory considerations; product development; market environment; product forecasts;
|
more...
|
$600.00
|
|
541711 Research and Development In Biotechnology: State Industry Market Evaluator
6/1/2012 | published by: BizMiner
This State Industry Market Evaluator reports on industry trends broken out for each US state. Each state sub-report is comprised of eight pages of data. Statistics are displayed for 2008-2009-2010 and 2011q2 for these measures:
|
more...
|
$699.00
|
|
Wound Care in Dominican Republic
5/9/2012 | published by: Euromonitor International
Consumers buy wound care products as part of first aid kits, with recommendations from the authorities to keep such items in the car, home and office for prompt application to a wound before receiving further
|
more...
|
$900.00
|
|
Wound Care in Guatemala
5/10/2012 | published by: Euromonitor International
In 2011, current value sales of wound care reached GTQ7 million after a 6% increase in current value terms. One of the key groups of consumers of wound care products are children. In Guatemala demographics
|
more...
|
$900.00
|
|
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development,
|
more...
|
$3,795.00
|
|
Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
5/1/2012 | published by: Current Partnering
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies.
|
more...
|
$2,695.00
|
|
Triple Analysis: Apoptosis, Protein Kinase Inhibitors and Antibodies
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors and by the compound strategy of Antibodies. Each of these three individual parts is evaluated
|
more...
|
$5,175.00
|
Related Markets
Biotechnology Reports
- Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides
- Triple Analysis: Melanoma, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
